Cymbalta has been approved by the U. Some patients have reported hallucinations as a side effect experienced from the withdrawal. The CDRS-R is a commonly used clinician-rated instrument that covers 17 symptom areas of depression relevant to adolescents, including impaired schoolwork, difficulty having fun, social withdrawal, physical complaints, and Side effects of drug lexapro low self-esteem. Further information on Lexapro is provided in the FDA Side effects of drug lexapro approved Package Insert. A double-blind, parallel-group, placebo-controlled phase III study to evaluate the safety and efficacy of Lexapro in the treatment of depressed adolescents, aged 12-17, was conducted in multiple centres across the US. Lexapro, also known by its scientific name Escitalopram, is a very popular antidepressant used to treat depression associated with mood disorders. As with all pharmaceutical companies, pipeline considerations influence stock side effects of drug lexapro valuation. The primary endpoint was change from baseline to Week 8 on the Childrens Depression Rating Scale – Revised CDRS-R using last observation carried forward LOCF approach. My PA had me return for a checkup one week after starting the medication and I felt great. These results suggest that Lexapro has potential as a useful treatment option for Side effects of drug lexapro adolescents with depression. The primary side effects of drug lexapro endpoint was change from baseline to Week 8 on the Childrens Depression Rating Scale – Revised CDRS-R using last observation carried forward LOCF approach. Also possible is severe irritability and sadness,depression like symptoms. The biggest change, I guess is that I went to the doctor. SSRIs and SNRIs have been associated with clinically significant hyponatremia. I think I saw side effects of drug lexapro her on a Thursday. For some, the drug was active on serotonin and probably was effective, side effects of drug lexapro and for others, it was a placebo effect. Forest Laboratories growing product line includes LexaproR escitalopram oxalate, an SSRI indicated for adults for the initial and maintenance treatment of major depressive disorder and generalized anxiety disorder; NamendaR memantine HCl, an N-methyl-D- aspartate NMd -receptor antagonist indicated for the treatment of moderate to severe Alzheimers disease; CampralR acamprosate calcium, indicated in combination with psychosocial support for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation; and BystolicTM nebivolol, a beta-adrenergic receptor blocking agent indicated for the treatment of hypertension. Balance sheet remains strong with zero long term debt.